Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate Cancer

NCT03124615 is registered in ClinicalTrials.gov with Macquarie University, Australia as lead sponsor.

NCT NCT03124615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03124615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate Cancer
Lead sponsor
Macquarie University, Australia
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2017
Completion date
June 30, 2021
Enrollment
47 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer